Seth Reno, Chief Commercial Officer at Gemphire Therapeutics Inc. (GEMP), bought 14,286 shares at $7.00 ($100K) on 2018-02-08, disclosed to the SEC on 2018-02-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.